Trials / Completed
CompletedNCT04794270
Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
This is a bilateral, dispensing, randomized, controlled, double-masked, 2×2 cross-over study to evaluate the clinical performance of ACUVUE OASYS® 1-Day for Astigmatism contact lenses produced on a recently qualified manufacturing line.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ACUVUE OASYS® 1-Day for Astigmatism - TAM 24 | TEST |
| DEVICE | ACUVUE OASYS® 1-Day for Astigmatism | CONTROL |
Timeline
- Start date
- 2021-03-02
- Primary completion
- 2021-04-13
- Completion
- 2021-04-13
- First posted
- 2021-03-12
- Last updated
- 2022-05-18
- Results posted
- 2022-05-18
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04794270. Inclusion in this directory is not an endorsement.